AllianceBernstein’s RxSight RXST Stock Holding History

AllianceBernstein’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	56,600 +21,000	+59%	+$127K	﹤0.01%	2915
2026 Q1	$371K	Hold	35,600	–	–	﹤0.01%	2789
2025 Q4	$371K	Hold	35,600	–	–	﹤0.01%	2807
2025 Q3	$320K	Sell	35,600 -1,500	-4%	-$13.2K	﹤0.01%	2916
2025 Q2	$482K	Hold	37,100	–	–	﹤0.01%	2659
2025 Q1	$937K	Hold	37,100	–	–	﹤0.01%	2281
2024 Q4	$1.28M	Hold	37,100	–	–	﹤0.01%	2197
2024 Q3	$1.83M	Hold	37,100	–	–	﹤0.01%	2007
2024 Q2	$2.23M	Buy	37,100 +6,760	+22%	+$386K	﹤0.01%	1885
2024 Q1	$1.56M	Buy	30,340 +11,000	+57%	+$540K	﹤0.01%	2047
2023 Q4	$780K	Hold	19,340	–	–	﹤0.01%	2393
2023 Q3	$539K	Hold	19,340	–	–	﹤0.01%	2537
2023 Q2	$557K	Buy	+19,340	New	+$430K	﹤0.01%	2578
2022 Q3	–	Sell	-17,194	Closed	-$242K	–	3300
2022 Q2	$242K	Buy	+17,194	New	+$227K	﹤0.01%	2953

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AllianceBernstein's RXST Position: Q2 2026 in Review

AllianceBernstein increased its RxSight (RXST) stake by 59% in Q2 2026, buying an estimated $127K and bringing the position to 56,600 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #2915.

AllianceBernstein first reported a position in RXST in Q2 2022 and has held it in 14 quarters since. The position peaked at $2.23M in Q2 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

AllianceBernstein held 56,600 shares of RxSight worth $349K as of Q2 2026.
AllianceBernstein bought 21,000 RxSight shares in Q2 2026, an estimated $127K.
RxSight made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2915 holding.
AllianceBernstein first reported a position in RxSight in Q2 2022 and has held it in 14 quarters since.
AllianceBernstein's RxSight position peaked at $2.23M in Q2 2024.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.